Click for best price
CAR Tcell Therapy Drug Market Size, Share 2023
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
This report aims to provide a comprehensive presentation of the global market for CAR T-cell Therapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-cell Therapy Drug. This report contains market size and forecasts of CAR T-cell Therapy Drug in global, including the following market information:
Global CAR T-cell Therapy Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global CAR T-cell Therapy Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CD19-targeted Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CAR T-cell Therapy Drug include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics and FOSUNKite, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CAR T-cell Therapy Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR T-cell Therapy Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CAR T-cell Therapy Drug Market Segment Percentages, by Type, 2022 (%)
CD19-targeted
BCMA-targeted
Global CAR T-cell Therapy Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CAR T-cell Therapy Drug Market Segment Percentages, by Application, 2022 (%)
Lymphoma
Multiple Myeloma
Global CAR T-cell Therapy Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CAR T-cell Therapy Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR T-cell Therapy Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR T-cell Therapy Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR T-cell Therapy Drug, market overview.
Chapter 2: Global CAR T-cell Therapy Drug market size in revenue.
Chapter 3: Detailed analysis of CAR T-cell Therapy Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR T-cell Therapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
CAR T-cell Therapy Drug Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAR T-cell Therapy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR T-cell Therapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-cell Therapy Drug Overall Market Size
2.1 Global CAR T-cell Therapy Drug Market Size: 2022 VS 2029
2.2 Global CAR T-cell Therapy Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-cell Therapy Drug Players in Global Market
3.2 Top Global CAR T-cell Therapy Drug Companies Ranked by Revenue
3.3 Global CAR T-cell Therapy Drug Revenue by Companies
3.4 Top 3 and Top 5 CAR T-cell Therapy Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR T-cell Therapy Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR T-cell Therapy Drug Players in Global Market
3.6.1 List of Global Tier 1 CAR T-cell Therapy Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-cell Therapy Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR T-cell Therapy Drug Market Size Markets, 2022 & 2029
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 By Type - Global CAR T-cell Therapy Drug Revenue & Forecasts
4.2.1 By Type - Global CAR T-cell Therapy Drug Revenue, 2018-2023
4.2.2 By Type - Global CAR T-cell Therapy Drug Revenue, 2024-2029
4.2.3 By Type - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR T-cell Therapy Drug Market Size, 2022 & 2029
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application - Global CAR T-cell Therapy Drug Revenue & Forecasts
5.2.1 By Application - Global CAR T-cell Therapy Drug Revenue, 2018-2023
5.2.2 By Application - Global CAR T-cell Therapy Drug Revenue, 2024-2029
5.2.3 By Application - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global CAR T-cell Therapy Drug Market Size, 2022 & 2029
6.2 By Region - Global CAR T-cell Therapy Drug Revenue & Forecasts
6.2.1 By Region - Global CAR T-cell Therapy Drug Revenue, 2018-2023
6.2.2 By Region - Global CAR T-cell Therapy Drug Revenue, 2024-2029
6.2.3 By Region - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America CAR T-cell Therapy Drug Revenue, 2018-2029
6.3.2 US CAR T-cell Therapy Drug Market Size, 2018-2029
6.3.3 Canada CAR T-cell Therapy Drug Market Size, 2018-2029
6.3.4 Mexico CAR T-cell Therapy Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe CAR T-cell Therapy Drug Revenue, 2018-2029
6.4.2 Germany CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.3 France CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.4 U.K. CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.5 Italy CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.6 Russia CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.7 Nordic Countries CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.8 Benelux CAR T-cell Therapy Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia CAR T-cell Therapy Drug Revenue, 2018-2029
6.5.2 China CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.3 Japan CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.4 South Korea CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.5 Southeast Asia CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.6 India CAR T-cell Therapy Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America CAR T-cell Therapy Drug Revenue, 2018-2029
6.6.2 Brazil CAR T-cell Therapy Drug Market Size, 2018-2029
6.6.3 Argentina CAR T-cell Therapy Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue, 2018-2029
6.7.2 Turkey CAR T-cell Therapy Drug Market Size, 2018-2029
6.7.3 Israel CAR T-cell Therapy Drug Market Size, 2018-2029
6.7.4 Saudi Arabia CAR T-cell Therapy Drug Market Size, 2018-2029
6.7.5 UAE CAR T-cell Therapy Drug Market Size, 2018-2029
7 CAR T-cell Therapy Drug Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR T-cell Therapy Drug Major Product Offerings
7.1.4 Novartis CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR T-cell Therapy Drug Major Product Offerings
7.2.4 Gilead Sciences CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Company Summary
7.4.2 J & J Business Overview
7.4.3 J & J CAR T-cell Therapy Drug Major Product Offerings
7.4.4 J & J CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Company Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR T-cell Therapy Drug Major Product Offerings
7.5.4 JW Therapeutics CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR T-cell Therapy Drug Major Product Offerings
7.6.4 FOSUNKite CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.6.5 FOSUNKite Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAR T-cell Therapy Drug Market Opportunities & Trends in Global Market
Table 2. CAR T-cell Therapy Drug Market Drivers in Global Market
Table 3. CAR T-cell Therapy Drug Market Restraints in Global Market
Table 4. Key Players of CAR T-cell Therapy Drug in Global Market
Table 5. Top CAR T-cell Therapy Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR T-cell Therapy Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR T-cell Therapy Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR T-cell Therapy Drug Product Type
Table 9. List of Global Tier 1 CAR T-cell Therapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR T-cell Therapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global CAR T-cell Therapy Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR T-cell Therapy Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis CAR T-cell Therapy Drug Product Offerings
Table 32. Novartis CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences CAR T-cell Therapy Drug Product Offerings
Table 36. Gilead Sciences CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offerings
Table 40. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Company Summary
Table 43. J & J CAR T-cell Therapy Drug Product Offerings
Table 44. J & J CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Company Summary
Table 47. JW Therapeutics CAR T-cell Therapy Drug Product Offerings
Table 48. JW Therapeutics CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Company Summary
Table 51. FOSUNKite CAR T-cell Therapy Drug Product Offerings
Table 52. FOSUNKite CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 53. FOSUNKite Key News & Latest Developments
List of Figures
Figure 1. CAR T-cell Therapy Drug Segment by Type in 2022
Figure 2. CAR T-cell Therapy Drug Segment by Application in 2022
Figure 3. Global CAR T-cell Therapy Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR T-cell Therapy Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CAR T-cell Therapy Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR T-cell Therapy Drug Revenue in 2022
Figure 8. By Type - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 16. US CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 20. Germany CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 28. China CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 34. Brazil CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 37. Turkey CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. J & J CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. JW Therapeutics CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. FOSUNKite CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
